Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

Previous retrospective studies have reported vigabatrin‐associated brain abnormalities on magnetic resonance imaging (VABAM), although clinical impact is unknown. We evaluated the association between vigabatrin and predefined brain magnetic resonance imaging (MRI) changes in a large homogenous tuberous sclerosis complex (TSC) cohort and assessed to what extent VABAM‐related symptoms were reported in TSC infants.

• Publication year

  2024

• Venue

  Epilepsia

• Publication date

  2024-12-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/epi.18190PMID 39641935PMCID 11827727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

  2024cited by this paper
• Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial

  2023cited by this paper
• Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy.

  2023cited by this paper
• Vigabatrin-associated brain abnormalities on MRI in tuberous sclerosis complex patients with infantile spasms: are they preventable?

  2022cited by this paper
• Vigabatrin-associated brain abnormalities on MRI and other neurological symptoms in patients with West syndrome.

  2022cited by this paper
• Hippocampal Involvement With Vigabatrin-Related MRI Signal Abnormalities in Patients With Infantile Spasms: A Novel Finding

  2021cited by this paper
• Perilesional white matter integrity in drug-resistant epilepsy related to focal cortical dysplasia.

  2021cited by this paper
• Altered Structural Brain Networks in Refractory and Nonrefractory Idiopathic Generalized Epilepsy

  2021cited by this paper
• Risk of vigabatrin‐associated brain abnormalities on MRI: A retrospective and controlled study

  2021cited by this paper
• Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis

  2020cited by this paper
• Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial

  2020cited by this paper
• Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex.

  2019cited by this paper
• Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study

  2018cited by this paper
• Influence of seizures on early development in tuberous sclerosis complex.

  2017cited by this paper
• Risk of vigabatrin‐associated brain abnormalities on MRI in the treatment of infantile spasms is dose‐dependent

  2017cited by this paper
• Neurological and neuropsychiatric aspects of tuberous sclerosis complex.

  2015cited by this paper
• Converting an odds ratio to a range of plausible relative risks for better communication of research findings

  2014cited by this paper
• Treatment of infantile spasms.

  2013cited by this paper
• Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex

  2013cited by this paper
• Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

  2013cited by this paper
• Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex.

  2012cited by this paper
• Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis.

  2011cited by this paper
• Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.

  2010cited by this paper
• Vigabatrin‐associated reversible MRI signal changes in patients with infantile spasms

  2010cited by this paper
• Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy

  2009cited by this paper
• Cerebral MRI abnormalities associated with vigabatrin therapy

  2009cited by this paper
• The natural history of epilepsy in tuberous sclerosis complex

  2009cited by this paper
• Transient magnetic resonance diffusion abnormalities in West syndrome: the radiological expression of non‐convulsive status epilepticus?

  2008cited by this paper
• Current management for epilepsy in tuberous sclerosis complex

  2006cited by this paper
• Vigabatrin for tuberous sclerosis complex.

  2001cited by this paper
• The Potential for Vigabatrin‐Induced Intramyelinic Edema in Humans

  2000cited by this paper
• Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.

  2000cited by this paper
• Topical Review: Vigabatrin in the Treatment of Infantile Spasms in Tuberous Sclerosis: Literature Review

  1999cited by this paper
• Vigabatrin-induced lesions in the rat brain demonstrated by quantitative magnetic resonance imaging.

  1994cited by this paper
• MRI monitoring of vigabatrin‐induced intramyelinic edema in dogs

  1994cited by this paper
• Infantile spasms

  1993cited by this paper
• Sequential Neuropathology of Dogs Treated with Vigabatrin, a GABA-Transaminase Inhibitor

  1993cited by this paper
• Effects of high-dose gamma-vinyl GABA (vigabatrin) administration on visual and somatosensory evoked potentials in dogs.

  1992cited by this paper
• Treatment of infantile spasms.

  1991cited by this paper
• Chronic Toxicity Studies with Vigabatrin, A GABA-Transaminase Inhibitor

  1990cited by this paper
• The Neuropathology of Vigabatrin

  1989cited by this paper
• Effects of vigabatrin on evoked potentials in dogs.

  1989cited by this paper
• Neuropathology of vigabatrin.

  1989cited by this paper
• The neuropathology of vigabatrin.

  1988cited by this paper
• A Study of the Effects of Vigabatrin on the Central Nervous System and Retina of Sprague Dawley and Lister-Hooded Rats

  1987cited by this paper
• A Coefficient of Agreement for Nominal Scales

  1960cited by this paper

• Efficacy and tolerability of early assessment of epileptic spasms to guide sequential treatment in children with infantile epileptic spasms syndrome:A nested case-control Study.

  2026cites this paper
• Tuberous Sclerosis Complex: An updated in the treatment of epilepsy for early careers.

  2025cites this paper
• Vigabatrin-associated brain abnormalities on MRI (VABAM) in children with epileptic spasms.

  2025cites this paper
• Vigabatrin-Associated Brain Magnetic Resonance Imaging Abnormalities in Two Children With WW domain-containing oxidoreductase-Related Epileptic Encephalopathy Syndrome.

  2025cites this paper
• Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

  2024cites this paper